{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:17:14Z","timestamp":1790705834270,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jaad.2020.08.117","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T11:26:53Z","timestamp":1599132413000},"page":"148-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Substance use disorders and chronic itch"],"prefix":"10.1016","volume":"84","author":[{"given":"Zoe M.","family":"Lipman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.08.117_bib1","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2018 National Survey on Drug Use and Health","year":"2019"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clindermatol.2010.03.024","article-title":"The effects of alcohol and drug abuse on the skin","volume":"28","author":"Liu","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2020.08.117_bib3","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/jid.2015.223","article-title":"Scratching induces overactivity in motor-related regions and reward system in chronic itch patients","volume":"135","author":"Mochizucki","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jaad.2020.08.117_bib5","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/exd.14029","article-title":"Addiction and the itch-scratch cycle. What do they have in common?","volume":"28","author":"Ishiuji","year":"2019","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.08.117_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.31887\/DCNS.2017.19.3\/gkoob","article-title":"Individual differences in the neuropsychopathology of addiction","volume":"19","author":"George","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib7","first-page":"325","article-title":"Practical guidelines for relief of itch","volume":"16","author":"Yosipovitch","year":"2004","journal-title":"Dermatol Nurs"},{"issue":"2","key":"10.1016\/j.jaad.2020.08.117_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2013.261","article-title":"The development and maintenance of drug addiction","volume":"39","author":"Wise","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jaad.2020.08.117_bib9","series-title":"basic and clinical pharmacology","author":"Katzung","year":"2017"},{"key":"10.1016\/j.jaad.2020.08.117_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2016.01.004","article-title":"Neural mechanisms of the nucleus accumbens circuit in reward and aversive learning","volume":"108","author":"Hikida","year":"2016","journal-title":"Neurosci Res"},{"issue":"46","key":"10.1016\/j.jaad.2020.08.117_bib11","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.1483-18.2018","article-title":"Dynamics and functional role of dopaminergic neurons in the ventral tegmental area during itch processing","volume":"38","author":"Yuan","year":"2018","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neuron.2019.03.030","article-title":"Central processing of itch in the midbrain reward center","volume":"102","author":"Su","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jaad.2020.08.117_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fpsyt.2016.00160","article-title":"Cognitive dysfunction, affective states, and vulnerability to nicotine addiction: a multifactorial perspective","volume":"7","author":"Besson","year":"2016","journal-title":"Front Psychiatry"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.neuroimage.2004.08.023","article-title":"Images of desire: food-cracing activation during fMRI","volume":"23","author":"Pelchat","year":"2004","journal-title":"Neuroimage"},{"issue":"51","key":"10.1016\/j.jaad.2020.08.117_bib15","doi-asserted-by":"crossref","first-page":"14035","DOI":"10.1523\/JNEUROSCI.2966-07.2007","article-title":"Neural substrates of abstinence-induced cigarette cravings in chronic smokers","volume":"27","author":"Wang","year":"2007","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.jaad.2020.08.117_bib16","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/jid.2008.3","article-title":"The brain processing of scratching","volume":"128","author":"Yosipovitch","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.08.117_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fphys.2019.00555","article-title":"The functional network processing acute electrical itch stimuli in humans","volume":"10","author":"Mochizuki","year":"2019","journal-title":"Front Physiol"},{"issue":"11","key":"10.1016\/j.jaad.2020.08.117_bib18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nn1579","article-title":"Neural systems of reinforcement for drug addiction: from actions to habits to compulsions","volume":"8","author":"Everitt","year":"2005","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0306-4522(00)00329-8","article-title":"Bi-directional changes in affective state elicited by manipulation of medullary modulatory circuitry","volume":"100","author":"Hirakawa","year":"2000","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jaad.2020.08.117_bib20","doi-asserted-by":"crossref","first-page":"11036","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.jaad.2020.08.117_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.biopsych.2010.08.002","article-title":"Opioid-dopamine interactions: implications for substance use disorders and their treatment","volume":"68","author":"Volkow","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.jaad.2020.08.117_bib22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2007.01.007","article-title":"Treatment of pruritus with topically applied opiate receptor antagonist","volume":"56","author":"Bigliardi","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.08.117_bib23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaci.2018.09.005","article-title":"Itch: from mechanism to (novel) therapeutic approaches","volume":"142","author":"Yosipovitch","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2020.08.117_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaad.2012.12.968","article-title":"Illicit drugs: what dermatologists need to know","volume":"69","author":"Hennings","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.08.117_bib25","series-title":"Central nervous system (CNS) stimulants. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2014"},{"issue":"1","key":"10.1016\/j.jaad.2020.08.117_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1529-8019.2008.00167.x","article-title":"Neuropathic and psychogenic itch","volume":"28","author":"Yosipovitch","year":"2008","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.jaad.2020.08.117_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128071-200102050-00003","article-title":"Delusions of parasitosis: a dermatologist's guide to diagnosis and treatment","volume":"2","author":"Koo","year":"2001","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.08.117_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamadermatol.2018.0004","article-title":"Prevalence of delusional infestation\u2014a population-based study","volume":"154","author":"Kohorst","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib29","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaad.2017.06.024","article-title":"An international study of the prevalence of substance use in patients with delusional infestation","volume":"77","author":"Lepping","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.08.117_bib30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.mehy.2006.07.061","article-title":"Delusional parasitosis and the dopamine transporter. A new insight of etiology?","volume":"68","author":"Huber","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jaad.2020.08.117_bib31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.pnpbp.2008.09.014","article-title":"Striatal lesions in delusional parasitosis revealed by magnetic resonance imaging","volume":"32","author":"Huber","year":"2008","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.jaad.2020.08.117_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2340\/00015555-3093","article-title":"Treatment-induced delusions of infestation associated with increased brain dopamine levels","volume":"99","author":"Fowler","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.08.117_bib33","first-page":"32","article-title":"Misdiagnosed pruritus; formication due to chronic amphetamine abuse","volume":"5","author":"Vahabzadeh","year":"2016","journal-title":"Asia Pac J Med Toxicol"},{"issue":"12","key":"10.1016\/j.jaad.2020.08.117_bib34","first-page":"12","article-title":"Amphetamine-induced delusional infestation","volume":"12","author":"Fisher","year":"2017","journal-title":"Am J Psyciatry Resid J"},{"issue":"7","key":"10.1016\/j.jaad.2020.08.117_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jaad.2020.08.117_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tins.2013.11.003","article-title":"Dopaminergic basis of salience dysregulation in psychosis","volume":"37","author":"Winton-Brown","year":"2014","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2133.1978.tb06541.x","article-title":"Successful treatment with pimozide of delusional parasitosis","volume":"98","author":"Rielly","year":"1978","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.08.117_bib38","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0190-9622(93)70284-Z","article-title":"Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach","volume":"29","author":"Driscoll","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.08.117_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archderm.142.3.352","article-title":"Successful treatment of delusions of parasitosis with olanzapine","volume":"142","author":"Meehan","year":"2006","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib40","first-page":"384","article-title":"Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation","volume":"23","author":"Brown","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jaad.2020.08.117_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jaad.2020.08.117_bib42","author":"Muhuri"},{"issue":"7","key":"10.1016\/j.jaad.2020.08.117_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaad.2020.08.117_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2230.2009.03463.x","article-title":"Opioid-induced pruritus: an update","volume":"35","author":"Reich","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2020.08.117_bib45","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.jaad.2020.08.117_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0310057X1204000204","article-title":"Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two","volume":"40","author":"Baldo","year":"2012","journal-title":"Anaesth Intensive Care"},{"issue":"2","key":"10.1016\/j.jaad.2020.08.117_bib47","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9554.1000337","article-title":"Dermatologic signs and symptoms of substance abuse","volume":"7","author":"Raiker","year":"2016","journal-title":"J Clin Exp Dermatol Res"},{"key":"10.1016\/j.jaad.2020.08.117_bib48","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.jid.5700661","article-title":"Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior","volume":"127","author":"Bigliardi-Qi","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.08.117_bib49","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1468-3083.2009.03129.x","article-title":"Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study","volume":"23","author":"Malekzad","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2020.08.117_bib50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.anai.2019.01.016","article-title":"Chronic itch management: therapies beyond those targeting the immune system","volume":"123","author":"Fowler","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2020.08.117_bib51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2340\/00015555-1353","article-title":"Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review","volume":"92","author":"Phan","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.08.117_bib52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"Phase 3 trial of difelikefalin in hemodialysis patients with pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.08.117_bib53","article-title":"Use of butorphanol as treatment for cholestatic itch","author":"Golpanian","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaad.2020.08.117_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","article-title":"Butorphanol for treatment of intractable pruritus","volume":"54","author":"Dawn","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.08.117_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2340\/00015555-0480","article-title":"In\u00a0vitro and in\u00a0vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus","volume":"88","author":"Lim","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2020.08.117_bib56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/ph12020095","article-title":"Therapeutic potential of kappa opioid agonists","volume":"12","author":"Beck","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.jaad.2020.08.117_bib57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaad.2016.02.1237","article-title":"Gabapentin and pregabalin for the treatment of chronic pruritus","volume":"75","author":"Matsuda","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.08.117_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2340\/00015555-2177","article-title":"Psychological interventions in the treatment of chronic itch","volume":"96","author":"Schut","year":"2016","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220325457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220325457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:57:56Z","timestamp":1759273076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220325457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0190962220325457"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.08.117","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance use disorders and chronic itch","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.08.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}